A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)
Condition(s):COVID-19Last Updated:March 3, 2021Completed
Hide Studies Not Open or Pending
Condition(s):COVID-19Last Updated:March 3, 2021Completed
Condition(s):Coronavirus Disease 2019 COVID-19Last Updated:May 6, 2023Completed
Condition(s):Coronavirus InfectionLast Updated:April 4, 2022Terminated
Condition(s):Middle East Respiratory Syndrome Coronavirus (MERS-CoV)Last Updated:January 18, 2024Completed
Condition(s):Coronavirus Disease 2019 (COVID-19)Last Updated:April 21, 2022Completed
Condition(s):Corona Virus Infection; COVID; Pregnancy Related; Early PregnancyLast Updated:January 24, 2024Active, not recruiting
Condition(s):Asymptomatic COVID-19 Infection Laboratory-Confirmed; Symptomatic COVID-19 Infection Laboratory-ConfirmedLast Updated:February 20, 2024Active, not recruiting
Condition(s):Coronavirus Disease 2019Last Updated:February 23, 2023Terminated
Condition(s):Exposure During Pregnancy; Corona Virus InfectionLast Updated:May 18, 2022Not yet recruiting
Condition(s):Covid19; Treatment; Corona Virus InfectionLast Updated:November 13, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.